122625-06-3

Upstream product

• 3587-60-8 Benzyloxymethyl chloride 
• 122624-87-7 (4S,5R)-4-<(Benzyloxy)methoxy>-2-hydroxy-5-methyl-5-(4-methyl-3-pentenyl)tetrahydrofuran 
• 122624-95-7 (2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2-<(Z)-2-chlorovinyl>tetrahydro-2,6-dimethyl-6-(4-methyl-3-pentenyl)-2H-pyran-3-ol 
• 122624-90-2 (2E,5S,6R)-5-<(Benzyloxy)methoxy>-2,6,10-trimethyl-6-(trimethylsiloxy)-2,9-undecadien-1-ol 
• 122624-92-4 (2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2,3-epoxy-2,6,10-trimethyl-6-(trimethylsiloxy)-9-undecenal 
• 122624-91-3 (2R,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2,3-epoxy-2,6,10-trimethyl-6-(trimethylsiloxy)-9-undecen-1-ol 
• 122624-98-0 <<(2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2-ethynyltetrahydro-2,6-dimethyl-6-(4-methyl-3-pentenyl)-2H-pyran-3-yl>oxy>trimethylsilane 
• 122625-05-2 (2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-3-<(2R,3R)-2,3-epoxy-3-methyl-4-pentenyl>tetrahydro-2,6-dimethyl-6-(4-methyl-3-pentenyl)-2H-pyran-3-ol 
• 122624-93-5 (1Z,3S,4R,6S,7R)-6-<(Benzyloxy)methoxy>-1-chloro-3,4-epoxy-3,7,11-trimethyl-7-(trimethylsiloxy)-1,10-dodecadiene 
• 122625-02-9 (βR,γR,2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-β,γ-epoxytetrahydro-β,2,6-trimethyl-6-(4-methyl-3-pentenyl)-3-(trimethylsiloxy)-2H-pyran-2-butanol 
• 122625-00-7 Ethyl 4-<(2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2,6-dimethyl-2-ethynyl-6-(4-methyl-3-pentenyl)-3-(trimethylsiloxy)tetrahydro-2H-pyran-2-yl>-(2E)-crotonate 
• 122625-03-0 (2R,3R)-4-<(2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2,6-dimethyl-6-(4-methyl-3-pentenyl)-3-(trimethylsiloxy)tetrahydro-2H-pyran-2-yl>-2,3-epoxy-3-methylbutyraldehyde 
• 122625-04-1 (2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2-<(2R,3R)-2,3-epoxy-3-methyl-4-pentenyl>tetrahydro-2,6-dimethyl-6-(4-methyl-3-pentenyl)-2H-pyran-3-ol 
• 122625-01-8 4-<(2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2,6-dimethyl-6-(4-methyl-3-pentenyl)-3-(trimethylsiloxy)tetrahydro-2H-pyran-2-yl>-(2E)-crotyl alcohol 

Relevant academic research and scientific papers

Synthesis of the FG Ring System of Brevetoxin B

A synthesis of an appropriately functionalized system (1) representing the FG ring skeleton of brevetoxin B is described.Beginning with the geraniol-derived lactone 6, the reported sequence proceeds via key intermediates 15 and 27 and involves two 6-endo selective hydroxy epoxide openings leading to the optically active target 1.The stereochemistry of the final product was confirmed by an X-ray crystallographic analysis of the crystalline derivative 30.